- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02774668
A Short Term Evaluation of a Structured Weight Loss Plan in Overweight and Obese Adults
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
It is well know that consumption of a calorically-restricted diet helps people lose weight. Such a diet with low carbohydrate lowers the serum uric acid concentration which is a factor associated with obesity and also represents a particular metabolic risk in women compared to men. The present weight loss study will determine whether women benefit more than men to short-term weight loss occurring during restriction of simple sugars.
Specifically, this study is designed to cause weight loss acutely through consumption of a diet that is restricted in calorie and simple sugars. Both men and women will be studied and their results compared to determine whether women benefit more with respect to arterial stiffness. Upon finishing the four-week diet intervention, body weight and blood lipids will be assessed two and four weeks later to compare the longer term effect on blood pressure.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Missouri
-
Columbia, Missouri, United States, 65212
- University of Missouri
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Men and premenopausal women
- 30-55 years of age
- Sedentary lifestyle, defined as less than three sessions of activity per week, or sessions less than 20 minutes per occasion, or less than 5000 steps per day
- Must be able to speak, read, and write English (due to the small sample size and pilot nature of this study)
- Overweight/obese subjects with BMI 27.0 - 40.0 kg/m2 and any one of the following characteristics of the metabolic syndrome:
A. Serum HDL cholesterol <40 mg/dL (1 mmol/L) in men and <50 mg/dL (1.3 mmol/L) in women B. Blood pressure ≥130/85 mmHg C. Fasting plasma glucose ≥100 mg/dL (5.6 mmol/L) D. Waist circumference in men of >102 cm (40 in) and in women of >88 cm (35 in) E. Serum triglycerides (TG) ≥150 mg/dL (1.7 mmol/L).
Exclusion Criteria:
- Abnormal thyroid function or known liver disease
- Diabetes or fasting glucose ≥ 125 mg/dL
- Use of medications that interfere with protein, carbohydrate or lipid metabolism (e.g., fish oil capsules)
- Occasional or regular tobacco use
- History of gout
- Uncontrolled hypertension
- Pregnant or peri-menopausal
- Vegetarian food restrictions (the diets consumed contain some meat, eggs and dairy)
- Alcohol intake: females > 70 g/wk, males >140 g/wk
- Moderate or vigorous-intensity physical activity, defined as more than 150 minutes per week of moderate-intensity, or 75 minutes a week of vigorous-intensity aerobic physical activity, or an equivalent combination of both.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: "Grab-and-Go" meal plan
The intervention of this arm is to use a "Grab-and-Go" meal plan.
This meal plan provides Atkins shakes and bars for breakfast, lunch, and snacks for 2 weeks.
For dinner the subject is given a freshly-prepared meal.
Upon finishing the 2-week provided food phase, the subject will consume a self-prepared meal of similar nutrient composition at home for another 2 weeks.
For the next four weeks while he/she is still enrolled in the study, he/she will have his/her options for food choices which are not controlled for the study.
|
The "Grab-and-Go" meal plan will provide Atkins shakes and bars for breakfast, lunch, and snacks. For dinner, the participant will receive a freshly-prepared meal. There will be no difference in terms of calories or nutrient composition between "Grab-and-Go" meal plan versus "Jump-Start" meal plan. The amount of weight loss caused by these two meal plans is not expected to differ. |
Active Comparator: "Jump-Start" meal plan
The intervention of this arm is to use a "Jump Start" meal plan.
This meal plan provides Atkins frozen meals at breakfast, lunch and dinner for 2 weeks and these meals are supplemented with fresh salads and vegetables.
Upon finishing the 2-week provided food phase, the subject will consume a self-prepared meal of similar nutrient composition at home for another 2 weeks.
For the next four weeks while he/she is still enrolled in the study, he/she will have his/her options for food choices which are not controlled for the study.
|
The "Jump-Start" plan will provide Atkins frozen meals at breakfast, lunch and dinner and these meals will be supplemented with fresh salads and vegetables.
There will be no difference in terms of calories or nutrient composition between "Grab-and-Go" meal plan versus "Jump-Start" meal plan.
The amount of weight loss caused by these two meal plans is not expected to differ.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Weight Loss Between Baseline and 4 Weeks After Completion of Dietary Intervention
Time Frame: Change of body weight over 4 weeks of dietary intervention
|
For statistical analysis, the body weight is measured at baseline and after 4 weeks after consumption of a calorie-restricted, low-carbohydrate diet.
|
Change of body weight over 4 weeks of dietary intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Arterial Stiffness Changes Between Baseline and 4 Weeks
Time Frame: Arterial stiffness will be measured at baseline and 4 weeks
|
Pulse wave velocity, a non-invasive indicator of arterial stiffness will be assessed at the baseline testing and 4 weeks after the start of the dietary intervention.
|
Arterial stiffness will be measured at baseline and 4 weeks
|
Plasma Uric Acid Level Between Baseline and 4 Weeks.
Time Frame: Plasma uric acid level will be measured at baseline and 4 weeks
|
A fasting blood sample will be collected at baseline, 4 weeks after the start of the dietary intervention to measure plasma uric acid level.
|
Plasma uric acid level will be measured at baseline and 4 weeks
|
Change in Food Craving Questionnaire (FCI-II-State) at Baseline and 4 Weeks
Time Frame: Questionnaires about food cravings will be administrated at baseline visit and 4 weeks after the start of the meal plan
|
Food craving questionnaire (FCI-II-State) will be administrated at baseline visit and the end of 4-week after dietary change. Cravings are assessed from 0 (no cravings: "Not at all") to 5 (high cravings: "Extremely/Always") for each of the five subscales measures including high-fat foods, sweets, carbohydrates/starches, fast-food fats, and fruits/vegetables. In addition, the scores for each of the subscales were averaged to produce a total cravings measure (also assessed from 0-5). |
Questionnaires about food cravings will be administrated at baseline visit and 4 weeks after the start of the meal plan
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Qiong Hu, PhD, University of Missouri-Columbia
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2004733
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metabolic Syndrome
-
Universidad de los Andes, ChileCompleted
-
Taipei Medical University WanFang HospitalUnknownMetabolic Cardiovascular SyndromeTaiwan
-
Mayo ClinicCompleted
-
SanofiBristol-Myers SquibbCompletedMetabolic Syndrome xUnited States
-
The Catholic University of KoreaCompletedMetabolic Syndrome X | Metabolic Cardiovascular Syndrome | Insulin Resistance Syndrome X | Dysmetabolic Syndrome XKorea, Republic of
-
Jordan Collaborating Cardiology GroupCardiovascular Academy; The Association of Jordanian Medical Laboratory Specialists...Not yet recruitingCardiovascular-renal-metabolic SyndromeJordan
-
University of HohenheimGerman Federal Ministry of Education and ResearchCompleted
-
Charite University, Berlin, GermanyRecruitingMetabolic Syndrome, Protection AgainstGermany
-
Wageningen University and ResearchPhilips Healthcare; TNO; Friesland Campina; Albert Heijn; Menzis; Smart with food; Vi... and other collaboratorsCompletedMetabolic Syndrome, Protection AgainstNetherlands
-
Cairo UniversityCompletedMetabolic Syndrome in WomenEgypt
Clinical Trials on "Grab-and-Go" meal plan
-
University of California, San FranciscoUniversity of Wisconsin, MadisonCompleted
-
Emory UniversityChildren's Healthcare of AtlantaCompletedAutism Spectrum DisorderUnited States
-
University of LeicesterTerminatedDietary ExposureUnited Kingdom
-
University of ConnecticutAcademy of Nutrition and Dietetics; Hartford HealthCare; Seafood Industry Research... and other collaboratorsActive, not recruitingDepression | Pain | Breast Cancer | Fatigue | Stress | Sleep Disturbance | Dietary Habits | SurvivorshipUnited States
-
Mondelēz International, Inc.KGK Science Inc.Completed
-
Abbott NutritionCompletedDiabetes Mellitus, Type 2United States
-
University of MinnesotaCompletedObesity | ChildUnited States
-
University Hospital, Clermont-FerrandCentre de Recherche en Nutrition Humaine d'AuvergneCompleted
-
Cedars-Sinai Medical CenterRecruiting